Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03580694 · TERMINATED
Trial details
- NCT number
- NCT03580694
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2019-12-04
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.